The global autoinjectors market is projected to grow at an annualized rate of ~10% and be worth around USD 2.5 Billion, till 2030

Roots Analysis has done a detailed study on Global Autoinjectors Market (3rd Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

 

To order this 600+ page report, which features 360+ figures and 350+ tables, please visit this link

 

Key Market Insights

• Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors, most of which are disposable systems that use prefilled syringes as primary drug containers
• About 90 autoinjector-based combination products have been approved for the treatment of a variety of clinical conditions; the subcutaneous route being the preferred mode of drug delivery via such devices
• In order to gain a competitive edge in the market, many autoinjector manufacturers are focusing on the integration of advanced features into their respective products and affiliated offerings
• Over time, more than 4,600 patents have been filed / granted related to autoinjectors and affiliated products; most of the new intellectual property is related to additional features, such as safety locks and device connectivity
• Eminent scientists from renowned organizations and academic institutions across the world have made valuable contributions to this field, in terms of leading clinical research efforts and developing novel technologies
• Several autoinjector developers have established strong brand positions in different geographies; the focus, in the near term, is likely to be on further enhancing device features for better disease management and improved patient compliance
• An evaluation of 200+ marketed and pipeline products revealed that a variety of drugs / product candidates are likely to be considered for administration via autoinjectors in the near future
• Case Study: Owing to the complexities associated with the manufacturing and assembly of autoinjector drug delivery systems, industry players are known to frequently engage the services of contract service providers
• Currently, disposable autoinjector products for small molecule drugs dominate the market; however, in the foreseen future, the demand for reusable devices is anticipated to witness significant growth
• Given the recent approvals and presence of multiple drug candidates in later stages of development, the market opportunity is likely to be distributed across different therapeutic areas, routes of administration and geographies

 

For more information, please visit  https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html

 

Table of Contents

 

1.              PREFACE

1.1.           Scope of the Report

1.2.           Research Methodology

1.3.           Chapter Outlines

 

2.              EXECUTIVE SUMMARY

                

3.              INTRODUCTION

3.1.           Chapter Overview

3.2.           Types of Drug Delivery Systems

3.3.           Drawbacks of Conventional Parenteral Delivery Systems

3.4.           Needlestick Injuries

3.4.1.        Incidence and Cost Burden

3.4.2.        Government Legislation for the Prevention of Needlestick Injuries           

                

3.5.           Emerging Trend of Self-Administration

3.5.1.        Rising Burden of Chronic Diseases

3.5.2.        Healthcare Cost Savings

3.5.3.        Need for Immediate Treatment in Emergency Situations

3.5.4.        Growth of Injectable Biologics Market

3.5.5.        Addressing Key User Safety Requirements

                

3.6.           Types of Self- Administration Devices

3.6.1.        Prefilled Syringes

3.6.2.        Pen-Injectors

3.6.3.        Needle-Free Injectors

3.6.4.        Autoinjectors

3.6.5.        Large Volume Wearable Injectors

                

3.7.           Overview of Autoinjectors

3.7.1.        Components of Autoinjectors

3.7.2.        Classification of Autoinjectors

3.7.2.1.      On the Basis of Mechanism of Action

3.7.2.2.      On the Basis of Usability

3.7.2.3.      On the Basis of Type of Dose

3.7.3.        Manufacturing / Packaging of Autoinjectors

3.7.4.        Benefits of Autoinjectors

                

3.8.           Regulatory Considerations

3.8.1.        Medical Devices

3.8.2.        Drug Device Combination Products

 

3.9.           Future Perspectives

                

4.              PRIMARY DRUG CONTAINERS

4.1.           Chapter Overview

4.2.           Types of Packaging

4.3.           Introduction to Primary Drug Containers

4.3.1.        Role of Primary Drug Containers

4.3.2.        Types of Primary Drug Containers

4.3.2.1.      Cartridges

4.3.2.1.1.   Components of Cartridges

4.3.2.1.2.   Types of Cartridges

4.3.2.1.2.1.  Single Chamber Cartridge

4.3.2.1.2.2.  Dual Chamber Cartridge

4.3.2.1.3.   Cartridges Available in the Market

                

4.3.2.2.      Syringes

4.3.2.2.1.   Components

4.3.2.2.2.   Types of Syringes

4.3.2.2.2.1.  Based on Number of Chambers

4.3.2.2.2.2.  Based on Type of Needle

4.3.2.2.3.   Prefilled Syringe Systems Available in the Market

4.3.2.2.3.1.  Glass Prefilled Syringes

4.3.2.2.3.2.  Plastic Prefilled Syringes

                

4.3.2.3.      Vials

4.3.2.3.1.   Components

4.3.2.3.2.   Vials Available in the Market

 

4.4.           Comparison of Fabrication Materials

                

5.              AUTOINJECTORS: CURRENT MARKET LANDSCAPE

5.1.           Chapter Overview

5.2.           Autoinjectors: List of Devices

5.2.1.        Analysis by Usability

5.2.2.        Analysis by Type of Primary Container

 

5.3.           Autoinjectors: List of Additional Parameters of Devices

5.3.1.        Analysis by Volume of Container

5.3.2.        Analysis by Type of Dose

5.3.3.        Analysis by Route of Administration

5.3.4.        Analysis by Actuation Mechanism

5.3.5.        Analysis by Type of Feedback Mechanism

                

5.4.           Autoinjectors: List of Developers

5.4.1.        Analysis by Year of Establishment

5.4.2.        Analysis by Company Size

5.4.3.        Analysis by Geographical Location of He